MannKind | GJELD



Debt Endring Dato
Adma Biologics USD 72.34M 28.99M 2024-12
Dynavax Technologies USD 223.85M 293K 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Insmed USD 1.13B 147.86M 2024-12
MacroGenics USD 0 0 2024-12
MannKind USD 289.64M 191.38M 2024-12
Merck USD 37.11B 1.02B 2024-12
Novo Nordisk DKK 56.97B 88M 2024-09
Pfizer USD 64.35B 3.35B 2024-12
Sanofi 21.05B 3.14B 2025-03
Xencor USD 163.61M 145.69M 2024-12



MannKind GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.